Related Experiment Video
Updated: Aug 31, 2026

Determining Bile Duct Density in the Mouse Liver
Published on: April 30, 2019
Bile Acid Profiles Define Disease-Specific Cholestatic States in Primary Sclerosing and Primary Biliary Cholangitis
Brian D Juran1, Bryan M McCauley2, Chang Hu3
1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Background And Aims:
Primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) are chronic cholestatic liver diseases with overlapping features but distinct biology. While bile acids (BAs) are central to cholestatic pathophysiology, the extent to which circulating BAs define disease-specific states remains unclear.
Methods:
Plasma BA profiling and clinical laboratory tests were performed in patients with PSC (n = 269), PBC (n = 262), and matched controls (n = 269/262), respectively. BA composition, conjugation patterns, and pool characteristics were compared within and across diseases. Associations with hepatic decompensation were evaluated using univariable and exploratory multivariable analyses, including comparison with established prognostic scores.
Results:
Both PSC and PBC exhibited elevated total BA levels compared with controls; however, BA composition and conjugation patterns differed between diseases. PSC was characterized by increased BA conjugation fraction and reduced glycine-to-taurine ratios, whereas PBC showed preserved overall conjugation with increased glycine predominance. In PSC, BA composition was further modulated by inflammatory bowel disease and colectomy, with depletion of secondary BA species. Across both diseases, advancing liver disease stage was associated with shifts toward primary and conjugated BA dominance. BA variables and clinical laboratory tests were associated with hepatic decompensation, particularly in PSC. Exploratory multivariable models showed comparable performance of BA-based and clinical laboratory-based models, and their combination did not materially improve prediction.
Conclusion:
Plasma BA profiles define distinct cholestatic states in PSC and PBC that reflect disease type, intestinal modifiers, and liver disease stage. While BA variables are associated with clinical outcomes, their principal value lies in complementing established clinical laboratory-based assessments rather than improving predictive accuracy.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Cholecystitis
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Bile
Bile is released when dietary fats enter...
Chronic Pancreatitis II: Pathophysiology
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
